The broad Swiss equity market has made strong gains since 23 March, with the Swiss Performance Index (SPI) now firmly back above the medium-term 63-day and long-term 200-day average. From a technical analysis perspective, we expect further upside potential for the Swiss stock market. Accelleron and Helvetia Baloise shares are particularly attractive, in our view.

Swiss Prime Site shares have made significant gains in relative strength versus the SPI benchmark index, showing positive technical trend and momentum indicators. From a technical analysis perspective, we expect further upside for Swiss Prime Site as well as a continuation of the intact relative outperformance versus the SPI and new record highs on an absolute basis.

BB Biotech AG’s share price is breaking out of a head and shoulders pattern and confirming a long-term bottom formation. From a technical analysis perspective, we expect further upside for BB Biotech AG as well as a continuation of the intact relative outperformance versus the SPI.